021-51111890
购物车（）
sales@molnova.cn
Boceprevir
CAS No. 394730-60-0
Boceprevir ( EBP 520;SCH 503034;EBP-520;EBP520;SCH-503034;SCH503034 )
产品货号. M14358 CAS No. 394730-60-0
A potent, selective, orally bioavailable HCV NS3 protease with Ki of 14 nM, EC90 of 350 nM in cell replicon assays.
纯度: >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
| 规格 | 价格/人民币 | 库存 | 数量 |
| 5MG | ￥527 | 有现货 |
|
| 10MG | ￥794 | 有现货 |
|
| 25MG | ￥1239 | 有现货 |
|
| 50MG | ￥1596 | 有现货 |
|
| 100MG | ￥2576 | 有现货 |
|
| 200MG | 获取报价 | 有现货 |
|
| 500MG | 获取报价 | 有现货 |
|
| 1G | 获取报价 | 有现货 |
|
生物学信息
-
产品名称Boceprevir
-
注意事项本公司产品仅用于科研实验，不得用于人体或动物的临床与诊断
-
产品简述A potent, selective, orally bioavailable HCV NS3 protease with Ki of 14 nM, EC90 of 350 nM in cell replicon assays.
-
产品描述A potent, selective, orally bioavailable HCV NS3 protease with Ki of 14 nM, EC90 of 350 nM in cell replicon assays; displays >2000-fold selectivity over human neutrophil elastase (HNE).HCV Infection Approved
-
同义词EBP 520;SCH 503034;EBP-520;EBP520;SCH-503034;SCH503034
-
通路Microbiology/Virology
-
靶点HCV
-
受体HCVNS3protease
-
研究领域Infection
-
适应症HCV Infection
化学信息
-
CAS Number394730-60-0
-
分子量519.68
-
分子式C27H45N5O5
-
纯度>98% (HPLC)
-
溶解度DMSO: ≥ 10 mg/mL
-
SMILESO=C([C@@H]1[C@@]2([H])C(C)(C)[C@@]2([H])CN1C([C@@H](NC(NC(C)(C)C)=O)C(C)(C)C)=O)NC(C(C(N)=O)=O)CC3CCC3
-
化学全称3-Azabicyclo[3.1.0]hexane-2-carboxamide, N-[3-amino-1-(cyclobutylmethyl)-2,3-dioxopropyl]-3-[(2S)-2-[[[(1,1-dimethylethyl)amino]carbonyl]amino]-3,3-dimethyl-1-oxobutyl]-6,6-dimethyl-, (1R,2S,5S)-
运输与储存
-
储存条件(-20℃)
-
运输条件With Ice Pack
-
稳定性≥ 2 years
参考文献
1. Venkatraman S, et al. J Med Chem. 2006 Oct 5;49(20):6074-86.
2. Sarrazin C, et al. Gastroenterology. 2007 Apr;132(4):1270-8.
3. Flint M, et al. Antimicrob Agents Chemother. 2009 Feb;53(2):401-11.
2. Sarrazin C, et al. Gastroenterology. 2007 Apr;132(4):1270-8.
3. Flint M, et al. Antimicrob Agents Chemother. 2009 Feb;53(2):401-11.
产品手册
关联产品
-
Paritaprevir
Paritaprevir (ABT-450, Veruprevir) is a potent HCV NS3/4A protease inhibitor with EC50 of 1 and 0.21 nM for HCV GT 1a and 1b, respectively.
-
Letermovir
Letermovir (AIC246) is a novel anti-CMV compound (EC50: about 5 nM in fibroblast cells).
-
LJH685
LJH685 is an effective pan-RSK inhibitor for RSK1/2/3 (IC50: 6/5/4 nM).
